Clinical features and prognostic predictors in patients with rheumatic diseases complicated by Pneumocystis pneumonia

• Published in: International journal of infectious diseases Vol. 122; pp. 1018 - 1025
• Main Authors: Huang, Yi-Min, Lu, Cheng-Hsun, Cheng, Chiao-Feng, Shen, Chieh-Yu, Hsieh, Song-Chou, Li, Ko-Jen, Chien, Jung-Yien, Hsueh, Po-Ren
• Format: Journal Article
• Language: English
• Published: Elsevier Ltd 01.09.2022; Elsevier
• Subjects: Adjunctive corticosteroid dosage; Mortality; Pneumocystis pneumonia; Pneumonia severity index; Rheumatic diseases; Pneumonia severity index; Adjunctive corticosteroid dosage; Mortality; Rheumatic diseases; Pneumocystis pneumonia

•Pneumocystis pneumonia (PCP) is a fatal complication in patients with rheumatic disease.•The dosage of adjunctive corticosteroids for PCP is debated in rheumatic diseases.•The optimal cutoff point of adjunctive corticosteroid dosage was 0.6 mg/kg/day.•An adjunctive corticosteroid dosage ≥0.6 mg/kg/...